Business Of Biotech
Durata totale:
35 h 35 min
Getting To A First Product Approval With Celcuity's Brian Sullivan
Business Of Biotech
50:16
Cell Therapy Advances And Biotech Leadership With Nkarta's Paul Hastings
Business Of Biotech
50:26
A Rescue Model For Shelved Drug Candidates With Annette Bakker, Ph.D. And Andrew Lo, Ph.D.
Business Of Biotech
55:43
Using Genetics To Discover New Treatments With Regeneron Genetics Center's Aris Baras, M.D.
Business Of Biotech
54:46
Late-Stage Development And Commercial Planning With CervoMed's Matt Winton, Ph.D.
Business Of Biotech
56:27
BoB@BIO: Biotech In The Balance With Ovid Therapeutics' Dr. Jeremy Levin
Business Of Biotech
48:57
BoB@BIO: Biotech Investing And Deals With Sofinnova's Maha Radhakrishnan, M.D.
Business Of Biotech
39:07
Targeting Tau in Alzheimer's Disease With Voyager Therapeutics' Al Sandrock, M.D., Ph.D.
Business Of Biotech
48:34
Keeping An Early-Stage Cell Therapy Biotech In The Black With IN8bio's William Ho
Business Of Biotech
55:13
Drug Launch Success In A Changing Commercial Landscape With ACMA's William Soliman, Ph.D.
Business Of Biotech
55:18
The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry
Business Of Biotech
84:17
Derisking CNS Drug Development With Tortugas Neuroscience's Jeff Jonas, M.D.
Business Of Biotech
49:52
Rare Disease Drug Commercialization With Zevra Therapeutics' Neil McFarlane
Business Of Biotech
55:23
Scaling Manufacturing For Personalized Cell Therapies With Cellino's Marinna Madrid, Ph.D.
Business Of Biotech
50:55
Building A New Antibody Discovery Platform With Infinimmune's Wyatt McDonnell, Ph.D.
Business Of Biotech
54:12
From Partnered ASO Therapies To A Wholly-Owned Pipeline With Ionis's Brett Monia, Ph.D.
Business Of Biotech
55:56
Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary
Business Of Biotech
47:37
The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw
Business Of Biotech
46:53
Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.
Business Of Biotech
58:33
Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor
Business Of Biotech
40:26
Investing In Early-Stage Oncology With Yosemite's Dan McHugh
Business Of Biotech
55:41
Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash
Business Of Biotech
50:57
Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.
Business Of Biotech
54:00
Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D.
Business Of Biotech
48:30
Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.
Business Of Biotech
53:57
An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.
Business Of Biotech
58:19
Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer
Business Of Biotech
56:56
Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie
Business Of Biotech
42:36
BoB@JPM: Brian Hilberdink, Boehringer Ingelheim
Business Of Biotech
44:35
BoB@JPM: Ron Cooper, enGene
Business Of Biotech
55:57
BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics
Business Of Biotech
36:08
A Royalty Model For Value Creation With Zymeworks' Kenneth Galbraith
Business Of Biotech
58:44
Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead
Business Of Biotech
81:12
Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos
Business Of Biotech
46:39
Modernizing Clinical Trial Operations With Merck's Jennifer Sheller
Business Of Biotech
55:39
Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.
Business Of Biotech
55:36
Engineering B Cells With Immusoft's Sean Ainsworth
Business Of Biotech
53:51
Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt
Business Of Biotech
51:25
Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.
Business Of Biotech
58:41
Biotech Funding And IPO Temperature Check With Create Medicine's Allan Shaw
Business Of Biotech
57:01
